Drugs

, Volume 56, Issue 4, pp 617–617 | Cite as

Rifapentine

A Viewpoint by C.M. Tam
  • C. M. Tam
Adis New Drug Profiles Guest Commentary
  • 13 Downloads

References

  1. 1.
    Tam CM, Chan SL, Lam CW, et al. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Int J Tuberc Lung Dis 1997; 1(5): 411–6PubMedGoogle Scholar
  2. 2.
    Tam CM, Shan SL, Lam CW, et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis: initial report. Am J Respir Crit Care Med 1998; 157: 1726–33PubMedGoogle Scholar
  3. 3.
    Vernon A, Villarino E, O’Brien R, et al. Relapse with rifampin mono-resistant TB (RMR-TB) in HIV-positive TB patients treated with a once weekly rifapentine-containing regimen. Int J Tuberc Lung Dis 1997; 1(5) Suppl. 1: S51–2Google Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • C. M. Tam
    • 1
  1. 1.Tuberculosis and Chest ServiceWanchai Chest ClinicHong Kong

Personalised recommendations